These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1789530)

  • 61. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 62. [Significance of selected immunological parameters in the diagnosis and follow-up of systemic lupus erythematosus].
    Wollina U; Knopf B; Koch HJ
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(4):697-700. PubMed ID: 6537639
    [No Abstract]   [Full Text] [Related]  

  • 63. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 64. [Biological diagnosis of systemic lupus erythematosus].
    Hilliquin P; Weill BJ
    Ann Med Interne (Paris); 1991; 142(7):515-20. PubMed ID: 1789530
    [No Abstract]   [Full Text] [Related]  

  • 65. What is the relationship between complement and systemic lupus erythematosus?
    Podrebarac TA; Goldstein R
    J Rheumatol; 1998 Nov; 25(11):2062-4. PubMed ID: 9818645
    [No Abstract]   [Full Text] [Related]  

  • 66. Autoantibodies in systemic lupus erythematosus.
    Amin SN; Maddison PJ
    J Assoc Physicians India; 1989 Aug; 37(8):529-31. PubMed ID: 2695515
    [No Abstract]   [Full Text] [Related]  

  • 67. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 68. Pathogenesis of systemic lupus erythematosus. Possible participation of antiphospholipid antibodies.
    Alarcón-Segovia D
    Isr J Med Sci; 1989 Dec; 25(12):669-74. PubMed ID: 2693397
    [No Abstract]   [Full Text] [Related]  

  • 69. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematosus and their clinical relevance. I. DNA-binding autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(3):127-34. PubMed ID: 6227213
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Complement and its breakdown products in SLE.
    Sturfelt G; Truedsson L
    Rheumatology (Oxford); 2005 Oct; 44(10):1227-32. PubMed ID: 15972354
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 72. Pathogenic role of auto-antibodies against complement components in systemic lupus erythematosus.
    Daha MR
    Lupus; 2008 May; 17(5):385-8. PubMed ID: 18490413
    [No Abstract]   [Full Text] [Related]  

  • 73. Autoantibodies in systemic rheumatic disorders clinical and diagnostic relevance.
    Genth E; Mierau R
    Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):149S-152S. PubMed ID: 9385666
    [No Abstract]   [Full Text] [Related]  

  • 74. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.